Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Role of pharmacogenetics in irinotecan therapy - de Jong_2006_Cancer.Lett_234_90 |
| Author(s) : de Jong FA , de Jonge MJ , Verweij J , Mathijssen RH |
| Ref : Cancer Letters , 234 :90 , 2006 |
| Abstract : de Jong_2006_Cancer.Lett_234_90 |
| ESTHER : de Jong_2006_Cancer.Lett_234_90 |
| PubMedSearch : de Jong_2006_Cancer.Lett_234_90 |
| PubMedID: 16343744 |
| Title : Irinotecan pathway genotype analysis to predict pharmacokinetics - Mathijssen_2003_Clin.Cancer.Res_9_3246 |
| Author(s) : Mathijssen RH , Marsh S , Karlsson MO , Xie R , Baker SD , Verweij J , Sparreboom A , McLeod HL |
| Ref : Clin Cancer Research , 9 :3246 , 2003 |
| Abstract : Mathijssen_2003_Clin.Cancer.Res_9_3246 |
| ESTHER : Mathijssen_2003_Clin.Cancer.Res_9_3246 |
| PubMedSearch : Mathijssen_2003_Clin.Cancer.Res_9_3246 |
| PubMedID: 12960109 |
| Gene_locus related to this paper: human-CES2 |
| Title : Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas - van den Bent_1998_Eur.J.Cancer_34_1570 |
| Author(s) : van den Bent MJ , Schellens JH , Vecht CJ , Sillevis Smit PA , Loosveld OJ , Ma J , Tijssen CC , Jansen RL , Kros JM , Verweij J |
| Ref : Eur J Cancer , 34 :1570 , 1998 |
| Abstract : van den Bent_1998_Eur.J.Cancer_34_1570 |
| ESTHER : van den Bent_1998_Eur.J.Cancer_34_1570 |
| PubMedSearch : van den Bent_1998_Eur.J.Cancer_34_1570 |
| PubMedID: 9893630 |